Eli Lilly and Company (LILY34) — Cash Flow Quality Index
Eli Lilly and Company (LILY34) has a Cash Flow Quality Index of 0.72x as of March 2026. Operating cash flow of R$5.33 Billion is below net income of R$7.40 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Eli Lilly and Company to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eli Lilly and Company Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Eli Lilly and Company across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Eli Lilly and Company operating cash flow efficiency.
Annual Cash Flow Quality Index for Eli Lilly and Company (2014–2025)
Year-by-year earnings quality comparison for Eli Lilly and Company.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | R$16.81 Billion | R$20.64 Billion | ▼ -2.2% |
| 2024 | 0.83x | R$8.82 Billion | R$10.59 Billion | ▼ -23.6% |
| 2023 | 1.09x | R$5.71 Billion | R$5.24 Billion | ▼ -3.9% |
| 2022 | 1.13x | R$7.08 Billion | R$6.24 Billion | ▼ -12.8% |
| 2021 | 1.30x | R$7.26 Billion | R$5.58 Billion | ▲ +24.0% |
| 2020 | 1.05x | R$6.50 Billion | R$6.19 Billion | ▲ +80.5% |
| 2019 | 0.58x | R$4.84 Billion | R$8.32 Billion | ▼ -66.0% |
| 2018 | 1.71x | R$5.52 Billion | R$3.23 Billion | ▼ -3.5% |
| 2016 | 1.77x | R$4.85 Billion | R$2.74 Billion | ▲ +44.0% |
| 2015 | 1.23x | R$2.96 Billion | R$2.41 Billion | ▼ -34.0% |
| 2014 | 1.87x | R$4.46 Billion | R$2.39 Billion | — |